Basophils, which constitute a small percentage of the total leukocyte count, are considered phagocytic. The basophilic granules contain heparin, histamines, and serotonin. Tissue basophils are called mast cells and are similar to blood basophils. Normally, mast cells are not found in peripheral blood and are rarely seen in healthy bone marrow.
Basophil counts are used to study chronic inflammation. There is a positive correlation between high basophil counts and high concentrations of blood histamines, although this correlation does not imply cause and effect. It is extremely difficult to diagnose basopenia because a 100010,000 count differential would have to be done to get an absolute count.
Obtain a 5-mL venous whole blood sample in a lavender-topped tube (with EDTA) and label the specimen with the patients name, date and time of collection, and test(s) ordered.
Count as part of the differential.
Basophilia (increased count) >50/mm3 or >0.05 × 109/L is commonly associated with the following:
Granulocytic (myelocytic) leukemia
Acute basophilic leukemia
Myeloid metaplasia, myeloproliferative disorders
Hodgkin disease
It is less commonly associated with the following:
Inflammation, allergy, or sinusitis
Polycythemia vera
Chronic hemolytic anemia
After splenectomy
After ionizing radiation
Hypothyroidism
Infections, including tuberculosis, smallpox, chickenpox, influenza
Foreign protein injection
Basopenia (decreased count) <20/mm3 or <0.02 × 109/L is associated with the following:
Acute phase of infection
Hyperthyroidism
Stress reactions (e.g., pregnancy, MI)
After prolonged steroid therapy, chemotherapy, radiation
Hereditary absence of basophils
Acute rheumatic fever in children
Presence of numbers of tissue mast cells (tissue basophils) is associated with the following:
RA
Urticaria, asthma
Anaphylactic shock
Hypoadrenalism
Lymphoma
Macroglobulinemia
Mast cell leukemia
Lymphoma invading bone marrow
Urticaria pigmentosa
Asthma
Chronic liver or renal disease
Osteoporosis
Systemic mastocytosis
Pretest Patient Care
Explain test purpose and procedure.
Refer to standard patient care for CBC and differential count. Also, follow guidelines in Chapter 1 for safe, effective, informed pretest care.
Posttest Patient Care
Review test results; report and record findings. Modify the nursing care plan as needed. Counsel the patient regarding abnormal findings; explain the need for possible follow-up testing and treatment.
Use special precautions if patient is receiving steroid therapy, epinephrine, thyroxine, or prostaglandins. Eosinophilia can be masked by steroid use.
Refer to standard posttest care for hemogram, CBC, and differential count. Also, follow guidelines in Chapter 1 for safe, effective, informed posttest care.
see Appendix E for drugs that affect test outcomes.